loader

cse:huge

LATEST ARTICLES
FSD Pharma Begins Phase 1 In-human Safety and Tolerability Study of Ultra Micro-Palmitolylethanolamide (PEA)
cannabis investing

FSD Pharma Begins Phase 1 In-human Safety and Tolerability Study of Ultra Micro-Palmitolylethanolamide (PEA)

CSE:HUGE
cannabis investing

FSD Pharma to Ring the Opening Bell of the Canadian Securities Exchange On Friday, March 6, 2020

Cannara Insiders Form Buying Group to Fully Acquire FSD/FV Pharma’s Position in Cannara
cannabis investing

Cannara Insiders Form Buying Group to Fully Acquire FSD/FV Pharma’s Position in Cannara

CSE:HUGE
cannabis investing

FSD Pharma Generates $7.7 Million in Proceeds and 670 Percent Return on Investment through Sale of Interest in Cannara Biotech

CSE:HUGE
cannabis investing

FSD Pharma Chairman & CEO to Present at 22nd Annual BIO CEO & Investor Conference in NYC

CSE:HUGE
cannabis investing

FSD Pharma and Solarvest Enhance Commitment to CBD Research Project

CSE:HUGE
cannabis investing

Seasoned Healthcare Executive and Academic Luminary Larry Kaiser, MD, Joins FSD Pharma Board of Directors

CSE:HUGE
cannabis investing

FSD Pharma to Ring Nasdaq Opening Bell on Wednesday, January 22, 2020

CSE:HUGE
cannabis investing

FSD Pharma to Commence Trading on Nasdaq Capital Market Under Symbol ‘HUGE’

CSE:HUGE
cannabis investing

FSD Pharma to Begin Trading on the NASDAQ Capital Market Under Symbol ‘HUGE’ on January 9, 2020

CSE:HUGE
cannabis investing

FSD Pharma Strengthens Management Team

CSE:HUGE
cannabis investing

FSD Pharma Receives Approval to List Its Shares on Nasdaq

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES